Core Insights - DaShi Intelligent has signed a strategic cooperation agreement with Rockwell Automation, focusing on low-carbon energy, biomedical laboratories, and smart healthcare [1][2] - The company aims to become a global leader in smart space services by leveraging its intelligent IoT platform to provide comprehensive lifecycle services [1][4] Strategic Cooperation - The partnership with Rockwell Automation builds on over 20 years of collaboration, enhancing capabilities in industrial automation and digital transformation [2] - DaShi Intelligent has previously partnered with Honeywell, transitioning from a sales agent to a self-research and development-focused company [2] User-Centric Innovation - The company emphasizes the need for customized solutions to meet specific user demands in smart buildings and hospitals, which often cannot be addressed by standardized products from multinational corporations [3] - Information security and cost optimization are critical factors driving the company's innovation efforts, with significant reductions in costs for domestic products compared to imported ones [3] Achievements and Goals - DaShi Intelligent's strategic goal for 2030 is to provide modular space applications and achieve a market penetration rate of 53.3% for its AIoT platform in enterprise and park intelligence projects by 2024 [4][5] - The company has successfully served 57 manufacturing listed companies in Shenzhen, achieving a coverage rate of 61.29% [4] Growth Factors - The significant growth in the AIoT platform's contract value, which increased by 102.9% year-on-year, is attributed to the emergence of domestic AI language models and long-term investments in AI applications [5][6] - Key growth strategies include increased R&D investment, market engagement through experiential marketing, and a focus on talent development [6] Commitment to Values - DaShi Intelligent's approach to innovation is rooted in understanding user needs, with a philosophy of "professionalism + sincerity" to create sustainable value [7][8] - The company has a history of developing products that meet user requirements, such as the first self-developed access control system in 1997, which provided cost-effective solutions compared to imported products [7][8] Future Outlook - Despite industry challenges, the emphasis on digital economy and rapid AI technology development presents opportunities for growth [9] - DaShi Intelligent has provided smart services to over 3,000 large and medium-sized enterprises across more than 200 cities, establishing a solid foundation for future development [9][10]

证券代码：002421 证券简称：达实智能 公告编号：2025-104 深圳达实智能股份有限公司 关于使用部分闲置募集资金进行现金管理的进展 公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳达实智能股份有限公司（以下简称"达实智能"或"公司"）于 2025 年 8 月 13 日召开了第八届董事会第二十一次会议，审议通过了《关于使用部分 闲置募集资金进行现金管理的议案》，为提高资金使用效率，增加存储收益，保 护投资者的权益，在确保不影响募集资金投资项目建设、不变相改变募集资金使 用用途、不影响公司正常运营及确保资金安全的情况下，同意公司使用不超过 5000 万元（含 5000 万元）闲置募集资金进行现金管理。自公司董事会审议通过 之日起 12 个月内有效，在决议有效期内，公司可根据产品期限在可用资金额度 内滚动使用。具体内容详见公司 2025 年 8 月 15 日披露于《证券时报》《证券日 报》和公司指定信息披露网站巨潮资讯网（http://www.cninfo.com.cn）的《关 于使用部分闲置募集资金进行现金管理的公告》（公告编号：2025-06 ...

Core Viewpoint - The company, Dasan Intelligent, primarily serves the domestic market with its smart and energy-saving business, while focusing on Southeast Asia and the Middle East for overseas markets. The company reported no direct revenue from Japan in the first three quarters of 2025, indicating that changes in Sino-Japanese relations do not significantly impact its operations [1]. Group 1 - The company's smart and energy-saving business mainly targets the domestic market [1] - The overseas market focus is on Southeast Asia and the Middle East [1] - There has been no direct revenue from Japan before the third quarter of 2025 [1] Group 2 - Changes in Sino-Japanese relations do not have a significant impact on the company's operations [1]

Market Overview - The medical consumables supply chain SPD sector experienced a decline of 1.42% on November 19, with Ailong Technology leading the drop [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Stock Performance - Key stocks in the medical consumables supply chain SPD sector showed mixed performance, with Jianfa Zhixin rising by 3.19% to a closing price of 34.00, while several others, including Guoyao Yici and Jiuzhoutong, saw declines of 0.55% and 0.59% respectively [1] - The trading volume and turnover for Jianfa Zhixin were 180,800 hands and 620 million yuan, respectively [1] Capital Flow - The medical consumables supply chain SPD sector saw a net outflow of 99.05 million yuan from main funds, while retail investors contributed a net inflow of 74.72 million yuan [2] - Notable individual stock capital flows included Jianfa Zhixin with a net inflow of 70.39 million yuan from main funds, while Ailong Technology experienced a net outflow of 2.99 million yuan [3]

Market Overview - The medical consumables supply chain SPD sector experienced a decline of 1.51% on November 17, with the leading stock, Kaikai Industrial, falling significantly [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers in the SPD sector included: - Langma Information: closed at 14.57, up 1.75% with a trading volume of 69,100 shares and a turnover of 100 million yuan - Dashi Intelligent: closed at 3.04, up 1.00% with a trading volume of 527,100 shares and a turnover of 160 million yuan - Guoxin Health: closed at 10.05, up 0.60% with a trading volume of 103,900 shares and a turnover of 104 million yuan [1] - Major decliners included: - Kaikai Industrial: closed at 14.83, down 4.14% with a trading volume of 312,500 shares and a turnover of 463 million yuan - Jianfa Zhixin: closed at 34.76, down 3.44% with a trading volume of 137,400 shares and a turnover of 481 million yuan - Yingte Group: closed at 11.85, down 2.79% with a trading volume of 87,300 shares and a turnover of 104 million yuan [2] Capital Flow - The SPD sector saw a net outflow of 244 million yuan from institutional investors, while retail investors contributed a net inflow of 241 million yuan [2] - The detailed capital flow for selected stocks showed: - Guokai Hengtai: net inflow of 7.31 million yuan from institutional investors - Dashi Intelligent: net outflow of 8.11 million yuan from retail investors - Langma Information: net outflow of 1.80 million yuan from retail investors [3]

Focus on Chengtun Mining - Company plans to invest approximately 1.423 billion RMB (19.995 million USD) in its subsidiary Chengtun Gold International through its wholly-owned subsidiary Hongsheng International Resources [1] Focus on Century Huatong - Company intends to repurchase shares worth between 500 million to 1 billion RMB, with a maximum repurchase price of 28.77 RMB per share [2] Focus on ST Zhongdi - Company stock experienced a significant price increase of 153.19% from October 16 to November 12, 2025, leading to a trading suspension for verification starting November 13, 2025 [3] Performance Highlights - BeiGene reported a revenue of 27.595 billion RMB for the first three quarters of 2025, marking a year-on-year growth of 44.2%, with a net profit of 1.139 billion RMB [4] Capital Increase & Restructuring - *ST Lian Stone received court approval for its restructuring plan, entering the execution phase after the termination of the restructuring process [5] Important Matters - Tuosda is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange, with discussions ongoing with relevant intermediaries [6] - North Medical's chairman and president were arrested for criminal charges, but the company's control and operations remain stable [7] - Nanjing Public Utilities is transferring 43.731 million shares, accounting for 7.61% of total shares, to Nanjing Innovation Investment Group for approximately 300 million RMB [8] Company Developments - Kaige Precision Machinery is establishing a joint venture with Zhangjiagang Wuyue Special Materials Technology, with an investment of 1 billion RMB for high-end component projects [9] - Stable Medical is investing approximately 2 billion RMB in a new production base for cotton non-woven fabric [10] - Fuchun Environmental is co-investing 116 million RMB in a combined heat and power project in Hubei [10] - Xingsheng Zhihui is collaborating with Beijing Automotive Group for resource sharing in the new energy vehicle sector [10] Stock Trading Updates - Huazhong Silver's subsidiary is undergoing a year-end maintenance shutdown, expected to last 20 days, with no impact on annual production plans [11] - San Yuan Co. clarified that its seasonal product, milk skin candy, has minimal revenue impact [12] - Chongqing Beer plans to distribute a cash dividend of 1.30 RMB per share, totaling approximately 629 million RMB [12] Stock Suspension - ST Zhongdi's stock is suspended for verification due to significant price fluctuations [15]

Group 1 - Peking University Medicine's chairman Xu Xiren has been arrested for criminal charges, but the company's control remains unchanged and operations are normal [3] - Victory Shares plans to issue shares and pay cash to acquire assets, along with raising supporting funds, following a significant stock price fluctuation [4] - Bangji Technology has terminated a major asset restructuring due to failure to reach an agreement with the counterparty, after experiencing a significant stock price drop [5] Group 2 - *ST Songfa has completed a major asset restructuring, changing its main business from ceramics to shipbuilding and high-end equipment [6] - Dongfang Yuhong plans to sell certain real estate assets, expecting a disposal loss of 25.81 million yuan, which exceeds 10% of its audited net profit for the last fiscal year [7] - Baili Tianheng has decided to delay its global H-share offering and listing due to current market conditions [8] Group 3 - Transsion Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its competitiveness and international brand image [9] - Shengtun Mining intends to invest approximately 1.423 billion yuan in its wholly-owned subsidiary, aiming to promote international development [10] - Haibo Sichuang has signed a strategic cooperation agreement with CATL, committing to a significant annual procurement of electricity [11] Group 4 - Century Huatong plans to repurchase shares worth between 500 million and 1 billion yuan, with a maximum repurchase price of 28.77 yuan per share [12] - Shannon Chip Innovation's major shareholder has reduced its stake by 549,200 shares, resulting in a slight decrease in ownership percentage [13] - Fangzheng Electric's shareholder Zhang Min has reduced his holdings by 1.6324 million shares, dropping below the 5% threshold [14] Group 5 - Haodangjia's controlling shareholder plans to reduce its stake by up to 2.7%, equating to approximately 39.45 million shares [15] - Zhibang Home's major shareholders have collectively reduced their convertible bond holdings by 13.51% [16] Group 6 - Longjian Shares has won a project worth 483 million yuan for road maintenance in Heilongjiang Province [17] - Zhejiang Communications has been awarded a project estimated at 11.103 billion yuan for urbanization construction [18] - Dash Smart has secured a project for the intelligentization of the new Huanggang Port, valued at 55.06 million yuan [19] Group 7 - Baiao Intelligent has signed a significant contract worth 97.22 million yuan for equipment sales [20] - Shaanxi Construction has won multiple projects exceeding 5 billion yuan, including a 5.12 billion yuan project in Zhejiang Province [21]

Core Points - The company, Dash Intelligent, announced that it has received a bid notification from the Shenzhen Municipal Bureau of Construction for the intelligent project of the New Huanggang Port Joint Inspection Building [1] - The winning bid amount for the project is 55.0564 million yuan [1]

Group 1 - Peking University Medicine's chairman Xu Xiren has been arrested for criminal charges, but the company's control remains unchanged and operations are normal [3] - Victory Shares plans to issue shares and pay cash to acquire assets, along with raising supporting funds, following a significant stock price fluctuation [4] - Bangji Technology has terminated a major asset restructuring due to failure to reach an agreement with the counterparty, after experiencing a significant stock price decline [5] Group 2 - ST Songfa has completed a major asset restructuring, changing its main business from ceramics to shipbuilding and high-end equipment [6] - Oriental Yuhong plans to sell certain properties, expecting to incur an asset disposal loss of 25.81 million yuan, which exceeds 10% of its audited net profit [7] - Baili Tianheng has decided to delay its global issuance and listing of H-shares due to current market conditions [8] Group 3 - Transsion Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its competitiveness and international brand image [9] - Shengtun Mining intends to invest approximately 1.423 billion yuan in its wholly-owned subsidiary Shengtun Gold International [11] - Haibo Sichuang has signed a strategic cooperation agreement with CATL, committing to a cumulative procurement of no less than 200 GWh of electricity from 2026 to 2028 [12] Group 4 - Century Huatong plans to repurchase shares worth between 500 million and 1 billion yuan, with a maximum repurchase price of 28.77 yuan per share [14] - Shannon Chip Innovation's major shareholder has reduced its stake by 549,200 shares, bringing its holding below 5% [16] - Fangzheng Electric's shareholder Zhang Min has reduced his stake by 1.6324 million shares, now holding 5% of the total shares [17] Group 5 - Longjian Co. has won a project worth 483 million yuan for road maintenance in Heilongjiang Province [21][22] - Zhejiang Communications has been awarded a project estimated at 11.103 billion yuan for new urbanization construction in Tonglu County [23] - Dash Smart has secured a project for the intelligent construction of the new Huanggang Port, with a contract value of 55.06 million yuan [24]

Group 1 - Longjian Co., Ltd. won a bid for a highway maintenance project in Heilongjiang with a contract value of 483 million yuan, accounting for 2.64% of the company's expected revenue for 2024 [1] - Transsion Holdings plans to issue H-shares and list on the main board of the Hong Kong Stock Exchange [1] - Good Home's controlling shareholder intends to reduce its stake by up to 2.7%, equivalent to no more than 39.4468 million shares [1][2] Group 2 - Xinhua Insurance reported a cumulative premium income of 181.973 billion yuan from January to October, representing a year-on-year growth of 17% [2][4] - Zhejiang Jiaokao is part of a consortium that plans to bid for a new urbanization project with an estimated total investment of 11.103 billion yuan [4] Group 3 - Changchun High-tech received approval for clinical trials of a vaccine for adolescents and adults [6] - XinNuoWei's application for the listing of Pertuzumab injection has been accepted, targeting HER2-positive breast cancer [8] - Dash Smart won a bid for an intelligent project at the new Huanggang Port inspection building, valued at 55.056 million yuan, which is 1.74% of its expected revenue for 2024 [8] Group 4 - Electronic City is involved in a lawsuit for debt recovery, with the amount in dispute estimated at 777 million yuan [9] - Haibo Technology signed a strategic cooperation agreement with CATL for a cumulative procurement of no less than 200 GWh of electricity from 2026 to 2028 [10] Group 5 - Renfu Pharmaceutical's HW231019 tablets have entered the second phase of clinical trials for postoperative pain relief [11] - Tonghua Dongbao received a drug registration certificate for Aspart Insulin injection from the Dominican Republic [11] Group 6 - Shaanxi Construction reported winning major projects worth a total of 1.016 billion yuan in October [12] - Fuzhou Environmental Protection plans to change its stock name to "Fuzhou Technology" [12] Group 7 - Panlong Pharmaceutical's gel patch for knee osteoarthritis has received approval for clinical trials [15] - Zhongyida's application for a specific stock issuance has been terminated by the Shanghai Stock Exchange [16] Group 8 - Zhizhong Home's controlling shareholder reduced its holdings of convertible bonds by 905,000 units, accounting for 13.51% of the total issued [19] - Haibo Co., Ltd. plans to establish a subsidiary with an investment of 1 billion yuan for high-end component projects [21] Group 9 - Caina Co. plans to use 57 million yuan of idle funds to purchase structured deposits [23] - Zhendong Pharmaceutical's new drug for acute ischemic stroke has entered the IIa phase of clinical trials [25] Group 10 - Weiman Sealing's overseas subsidiary plans to lease a factory in Saudi Arabia for 5 years at a total rent of approximately 54.039 million yuan [26] - Yiling Pharmaceutical's application for Memantine Hydrochloride has been approved for market entry [28] Group 11 - Dongfang Zhizao plans to acquire 70% of Saifu Machinery for 27.4887 million yuan [30] - JianKai Technology's actual controller intends to transfer 3% of the company's shares through inquiry [31] Group 12 - Rejing Bio plans to repurchase shares worth between 100 million and 200 million yuan [32] - Bangji Technology has decided to terminate a major asset restructuring project due to failure to reach an agreement [34] Group 13 - Huadong Pharmaceutical's application for the marketing license of a new drug has been accepted [36] - Zhonggu Logistics' shareholder plans to reduce its stake by up to 3% [38] Group 14 - Bohui Innovation's subsidiary received approval for a clinical trial of a vaccine for invasive infections [40] - Shannon Chip's shareholder pledged 0.27% of the company's shares for financing [42] Group 15 - Shanghai Petrochemical appointed a new general manager [44] - Jiaojian Co. plans to reduce the holdings of some directors and executives by up to 0.35% [46] Group 16 - Weiting Electric plans to raise no more than 300 million yuan through a private placement [47] - Zhongjin Irradiation plans to invest approximately 200 million yuan in an electronic accelerator manufacturing project [49] Group 17 - Tongxing Technology signed a framework agreement to invest 3.2 billion yuan in a sodium battery project [50] - Hongri Da plans to establish a subsidiary focused on semiconductor packaging [51] Group 18 - Shanghai Kaibao's new drug for acute ischemic stroke has received approval for clinical trials [53] - Yitong Century announced a change in its control structure, becoming a company without a controlling shareholder [55]